BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12719294)

  • 41. Assessment and treatment of hypertension in dialysis: the case for salt restriction.
    Sanders PW
    Semin Dial; 2007; 20(5):408-11. PubMed ID: 17897246
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin].
    Os I; Kjeldsen SE; Beckmann SL; Eide I; Hjermann I; Leren P; Westheim A
    Tidsskr Nor Laegeforen; 1987 Apr; 107(10-11):954-7. PubMed ID: 3299859
    [No Abstract]   [Full Text] [Related]  

  • 43. [Changes in the functional activity of the sympathetico-adrenal system after correction of electrolyte metabolism in patients with hypertension].
    Bakhshaliev AV; Gadzhiev RF
    Klin Med (Mosk); 1989 May; 67(5):64-7. PubMed ID: 2770212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adrenosympathetic activity during sodium depletion in patients with essential hypertension].
    Agabiti-Rosei E; Alicandri C; Bentivoglio M; Corea L; Miele N; Muiesan G
    Boll Soc Ital Cardiol; 1977; 22(8):1413-20. PubMed ID: 618275
    [No Abstract]   [Full Text] [Related]  

  • 45. [Mechanism of blood pressure reduction during caloric reduction in obese hypertensives].
    Kajiwara N; Kobayashi F; Kushiro T; Hasegawa M
    Nihon Rinsho; 1992 May; 50 Suppl():426-31. PubMed ID: 1512981
    [No Abstract]   [Full Text] [Related]  

  • 46. Salt intake and sympathetic activity.
    He FJ; MacGregor GA
    Circulation; 2003 Apr; 107(16):e108; author reply e108. PubMed ID: 12719294
    [No Abstract]   [Full Text] [Related]  

  • 47. Translation of salt retention to central activation of the sympathetic nervous system in hypertension.
    Brooks VL; Haywood JR; Johnson AK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):426-32. PubMed ID: 15854153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonpharmacologic treatment of hypertension: a review.
    Lehmann JW; Benson H
    Gen Hosp Psychiatry; 1982 Apr; 4(1):27-32. PubMed ID: 7042456
    [No Abstract]   [Full Text] [Related]  

  • 49. [Reducing food salt content--a neglected approach to hypertension prevention and treatment in the population].
    Horký K
    Vnitr Lek; 2009 Sep; 55(9):797-801. PubMed ID: 19785379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension.
    Kawano Y; Ando K; Matsuura H; Tsuchihashi T; Fujita T; Ueshima H;
    Hypertens Res; 2007 Oct; 30(10):879-86. PubMed ID: 18049018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The sympathetic nervous system in human hypertension.
    Mancia G; Grassi G; Parati G; Zanchetti A
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II15-9. PubMed ID: 10874852
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sympathetic nervous system and hypertension].
    Teicher A; Rosenthal T
    Harefuah; 1982 Jun; 102(11):483-8. PubMed ID: 6761243
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.